Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

0.00%

8.0¢ kazia therapeutics limited

Dana-Farber Cancer - phosphoinositide 3 (PI3) kinase, page-2

First 2 Last

Share
Profile

Follow
Gofish1

909 Posts.

101

06/12/21

09:34

Post #: 58089952
Share

Originally posted by Rich&Poor: ↑

Dana-Farber Cancer - phosphoinositide 3 (PI3) kinaseRecent post by Lab Man (Stock twits).

$KZIA Lewis Cantley is soon to join Dana Farber. It is said that his move from Weill Cornell, to team with Tom Roberts and Jean Zhao from DF, will create a dream team approach for the development of phosphatidylinositol inhibitors.
Dr. Roberts is a Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and serves as Co-Chairman for the Department of Cancer Biology at Dana-Farber Cancer Institute. The first definitive studies on phosphoinositide 3 (PI3) kinase were done by the Roberts lab in collaboration with the lab of Lewis Cantley. Dr Roberts has studied PI3K in detail, collaborating with Jean Zhao and Priscilla Brastianos, to generate conditional knockout mice for the commonly expressed catalytic subunits of PI3K. The end goal of these studies, determining which isoforms to target in specific cancers. In recent times, KZIA has collaborated in a total of 7 clinical trials with Harvard Medical and Weill Cornell.

Exciting times ahead for paxalisib and maybe a new trial in combination with other drugs.

Regards.

Expand

Looks like Lewis Cantley was recruited by his old boss.

https://www.statnews.com/2016/03/01/laurie-glimcher-dana-farber/

https://endpts.com/scoop-famed-cancer-researcher-and-biotech-founder-lew-cantley-is-headed-to-dana-farber/

KZA Price at posting: $1.43 Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

First 2 Last

Add KZA (ASX) to my watchlist

Dana-Farber Cancer - phosphoinositide 3 (PI3) kinase, page-2

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News